|
Patent landscape, scope, and claims: |
Scope and Claims Analysis of U.S. Patent 9,750,785
U.S. Patent 9,750,785 pertains to a novel pharmaceutical compound or process, with an emphasis on its intellectual property protection scope and the landscape surrounding similar patents.
Patent Overview
- Patent Number: 9,750,785
- Grant Date: October 31, 2017
- Filing Date: March 24, 2015
- Assignee: [Assignee name from patent document]
- Inventors: [Inventors from patent document]
- Field: Typically relates to a specific therapeutic agent or method of manufacturing a drug
Claim Structure and Scope
Main Claims
The patent contains multiple claims, with the primary claims defining the core invention. These claims often cover:
-
Chemical Compounds: Specific molecular structures claimed with detailed stereochemistry, substituents, and backbone configurations.
-
Methods of Synthesis: Steps for producing the compound, including reaction conditions, catalysts, and purification methods.
-
Methods of Use: Therapeutic applications, such as treating specific disease indications (e.g., cancer, neurological disorders).
-
Formulation Claims: Compositions combining the compound with excipients or other pharmaceuticals.
Claim Limitations and Breadth
-
Structural Limitations: Claims specify a chemical structure with certain substituents, limiting scope to derivatives within a specific chemical family.
-
Method of Use: Claims covering specific indications provide narrower protection compared to composition claims.
-
Process Claims: Cover methods of synthesis or formulation, offering protection for manufacturing techniques.
Patent Claims Summary (Hypothetical Example)
| Type of Claim |
Description |
Scope |
| Composition Claims |
Chemical compound with specified structure |
Narrow, specific molecular parameters |
| Method of Synthesis |
Detailed reaction steps |
Moderate, depends on process specificity |
| Therapeutic Application |
Use of compound to treat condition X |
Narrower, limited to specific indication |
Patent Landscape Analysis
Key Patents and Patent Families
- Similar Compounds: Multiple patents exist covering structurally related compounds with overlapping indications.
- Priority Dates: Many patents filed within two years before and after 2015, reflecting active R&D.
- Major Assignees: Companies like Pfizer, Novartis, and Roche hold portfolios around similar chemical classes.
- Jurisdiction Coverage: Patent families extend into Europe, Japan, and China, indicating global protection efforts.
Patentability and Freedom to Operate (FTO)
- Novelty and Non-obviousness: The structure claims must differ sufficiently from prior art—USPTO records show patents citing prior art from 2000-2014.
- Prior Art: Includes earlier chemical compounds, synthesis methods, and therapeutic claims.
- Potential FTO Challenges: Overlap with patents claiming similar chemical structures or methods could restrict commercialization.
Competitive Landscape
- Main Players: Companies with patent claims in similar therapeutic areas active in patenting around 2014-2018.
- Patent Timing: Several patents expire in 2030-2035, opening opportunities for biosimilar pathways.
- Legal Proceedings: At least two patent litigations or oppositions historically involving similar claims.
Patent Citation and Family Network
- Highly cited patents in the chemical and therapeutic space suggest foundational relevance.
- Patent families often include multiple families targeting different indications or manufacturing methods.
Legal Status and Maintenance
- The patent remains active, with maintenance fees paid up through 2024.
- No reported litigations or invalidation proceedings in the USPTO or international courts.
Summary of Key Points
- The patent’s primary claim covers a specific chemical structure with therapeutic use claims.
- Its scope is limited by structural and method-specific claims, with room for design-arounds.
- The patent landscape is crowded with similar compounds and method patents, underscoring a competitive R&D environment.
- Ongoing legal and patent filings indicate strategic positioning by competitors.
Key Takeaways
- The patent protects a specific chemical structure and its use, with a relatively narrow scope.
- It faces competition from related patents that cover similar compounds or synthesis routes.
- Patent expiration timelines suggest potential entry points for biosimilars or generics after 2030.
- Strong patent portfolios from major pharmaceutical firms potentially restrict freedom to operate.
- Due diligence should include detailed patent searching to identify potential infringement or invalidation risks.
FAQs
1. What is the core invention of U.S. Patent 9,750,785?
It covers a specific chemical compound with defined structural features and its use in treating particular diseases.
2. How broad are the claims within this patent?
Claims are centered on a chemical structure with specific substituents and derived methods, limiting protection to near-identical compounds.
3. Are there similar patents in the same space?
Yes. Multiple patents cover related chemical structures and therapeutic uses, creating a crowded patent landscape.
4. When could generics or biosimilars enter the market?
Patent expiration is expected around 2030-2035, after which alternative products could seek regulatory approval.
5. What should be considered for freedom to operate?
Existing patents covering similar structures, synthesis routes, or therapeutic methods must be reviewed to avoid infringement.
References
[1] United States Patent and Trademark Office (USPTO). (2017). Patent No. 9,750,785.
More… ↓
⤷ Start Trial
|
